Some of you may have seen the headlines this week about JDRF and Amylin investigating a new diabetes treatment – essentially a mixture of insulin and pramlintide (brand name Symlin), two substances that are only FDA approved for entirely separate …
SOURCE: Healthline RSS Feed – Read entire story here.